These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24901677)

  • 41. Associations between physical and cognitive doping--a cross-sectional study in 2.997 triathletes.
    Dietz P; Ulrich R; Dalaker R; Striegel H; Franke AG; Lieb K; Simon P
    PLoS One; 2013; 8(11):e78702. PubMed ID: 24236038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Qualitative evidence of a primary intervention point for elite athlete doping.
    Mazanov J; Huybers T; Connor J
    J Sci Med Sport; 2011 Mar; 14(2):106-10. PubMed ID: 20708965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nutritional supplement practices in UK junior national track and field athletes.
    Nieper A
    Br J Sports Med; 2005 Sep; 39(9):645-9. PubMed ID: 16118303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Supplement Use of Elite Australian Swimmers.
    Shaw G; Slater G; Burke LM
    Int J Sport Nutr Exerc Metab; 2016 Jun; 26(3):249-58. PubMed ID: 26630501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug misuse in sport: a New Zealand perspective.
    Curtis A; Gerrard D; Burt P; Osborne H
    N Z Med J; 2015 Dec; 128(1426):62-8. PubMed ID: 26913908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting attitude towards performance enhancing substance use: a comprehensive test of the Sport Drug Control Model with elite Australian athletes.
    Jalleh G; Donovan RJ; Jobling I
    J Sci Med Sport; 2014 Nov; 17(6):574-9. PubMed ID: 24268440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. National doping prevention guidelines: Intent, efficacy and lessons learned - A 4-year evaluation.
    Wippert PM; Fließer M
    Subst Abuse Treat Prev Policy; 2016 Oct; 11(1):35. PubMed ID: 27724975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of supplements by Japanese elite athletes for the 2012 Olympic Games in London.
    Sato A; Kamei A; Kamihigashi E; Dohi M; Akama T; Kawahara T
    Clin J Sport Med; 2015 May; 25(3):260-9. PubMed ID: 24942621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein supplements and adolescent athletes: A pilot study investigating the risk knowledge, motivations and prevalence of use.
    Whitehouse G; Lawlis T
    Nutr Diet; 2017 Nov; 74(5):509-515. PubMed ID: 28748643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Self-admitted behavior and perceived use of performance-enhancing vs psychoactive drugs among competitive athletes.
    Uvacsek M; Nepusz T; Naughton DP; Mazanov J; Ránky MZ; Petróczi A
    Scand J Med Sci Sports; 2011 Apr; 21(2):224-34. PubMed ID: 19903314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of drugs and nutritional supplements in top-level track and field athletes.
    Tscholl P; Alonso JM; Dollé G; Junge A; Dvorak J
    Am J Sports Med; 2010 Jan; 38(1):133-40. PubMed ID: 19812387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medication use by athletes during the Athens 2004 Paralympic Games.
    Tsitsimpikou C; Jamurtas A; Fitch K; Papalexis P; Tsarouhas K
    Br J Sports Med; 2009 Dec; 43(13):1062-6. PubMed ID: 19850571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analgesics use in competitive triathletes: its relationship to doping and on predicting its usage.
    Dietz P; Dalaker R; Letzel S; Ulrich R; Simon P
    J Sports Sci; 2016 Oct; 34(20):1965-9. PubMed ID: 26911564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nutritional supplements in Norwegian elite athletes--impact of international ranking and advisors.
    Sundgot-Borgen J; Berglund B; Torstveit MK
    Scand J Med Sci Sports; 2003 Apr; 13(2):138-44. PubMed ID: 12641646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inevitable? Doping attitudes among Berliners in 2011: the role of socialist state socialisation and athlete experience.
    Wagner GG; Ziebarth NR
    Eur J Public Health; 2016 Jun; 26(3):520-2. PubMed ID: 27056894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IOC Consensus Statement: Dietary Supplements and the High-Performance Athlete.
    Maughan RJ; Burke LM; Dvorak J; Larson-Meyer DE; Peeling P; Phillips SM; Rawson ES; Walsh NP; Garthe I; Geyer H; Meeusen R; van Loon L; Shirreffs SM; Spriet LL; Stuart M; Vernec A; Currell K; Ali VM; Budgett RGM; Ljungqvist A; Mountjoy M; Pitsiladis Y; Soligard T; Erdener U; Engebretsen L
    Int J Sport Nutr Exerc Metab; 2018 Mar; 28(2):104-125. PubMed ID: 29589768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and patterns of dietary supplement use in elite Spanish athletes.
    Baltazar-Martins G; Brito de Souza D; Aguilar-Navarro M; Muñoz-Guerra J; Plata MDM; Del Coso J
    J Int Soc Sports Nutr; 2019 Jul; 16(1):30. PubMed ID: 31319850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug testing in elite athletes--the Israeli perspective.
    Epstein S; Eliakim A
    Isr Med Assoc J; 1999 Oct; 1(2):79-82. PubMed ID: 10731300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gender- and Sport-Specific Associations Between Religiousness and Doping Behavior in High-Level Team Sports.
    Zvan M; Zenic N; Sekulic D; Cubela M; Lesnik B
    J Relig Health; 2017 Aug; 56(4):1348-1360. PubMed ID: 27167741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Self-control, self-regulation, and doping in sport: a test of the strength-energy model.
    Chan DK; Lentillon-Kaestner V; Dimmock JA; Donovan RJ; Keatley DA; Hardcastle SJ; Hagger MS
    J Sport Exerc Psychol; 2015 Apr; 37(2):199-206. PubMed ID: 25996110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.